[
  {
    "ts": null,
    "headline": "January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week",
    "summary": "Crucial labor market data, more earnings from Big Tech giants, and continued discussion over where Kevin Warsh may lead the central bank should set the agenda in the week ahead.",
    "url": "https://finnhub.io/api/news?id=22a75c6698ef0c76639591b1eb45c7cf7117cb7863e10896a6b1489fadf887dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769950043,
      "headline": "January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week",
      "id": 138323726,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Crucial labor market data, more earnings from Big Tech giants, and continued discussion over where Kevin Warsh may lead the central bank should set the agenda in the week ahead.",
      "url": "https://finnhub.io/api/news?id=22a75c6698ef0c76639591b1eb45c7cf7117cb7863e10896a6b1489fadf887dd"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Reshapes Portfolio With Nalu And Penumbra Neuro Deals",
    "summary": "Boston Scientific (NYSE:BSX) has completed the acquisition of Nalu Medical, expanding its presence in chronic pain treatment. The company has announced a pending US$14.5b deal for Penumbra, which would significantly increase its scale in neurovascular devices. These transactions represent a major reshaping of BSX’s portfolio in neuromodulation and neurovascular care. Boston Scientific is a large medical device company with products across cardiology, peripheral interventions, urology and...",
    "url": "https://finnhub.io/api/news?id=690732742fb7815347c7cbfdd03bbb90faa2dcb70ae48af0f05b5d8ca6f8587e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769940353,
      "headline": "Boston Scientific Reshapes Portfolio With Nalu And Penumbra Neuro Deals",
      "id": 138323146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (NYSE:BSX) has completed the acquisition of Nalu Medical, expanding its presence in chronic pain treatment. The company has announced a pending US$14.5b deal for Penumbra, which would significantly increase its scale in neurovascular devices. These transactions represent a major reshaping of BSX’s portfolio in neuromodulation and neurovascular care. Boston Scientific is a large medical device company with products across cardiology, peripheral interventions, urology and...",
      "url": "https://finnhub.io/api/news?id=690732742fb7815347c7cbfdd03bbb90faa2dcb70ae48af0f05b5d8ca6f8587e"
    }
  }
]